Martha J. Carter

Insider Reports History

Entity
Individual
Location
C/O Aegerion Pharmaceuticals, Inc., 89 Headquarters Plaza, Suite 1212, Morristown, NJ
Signature
/s/ Jason Duncan, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martha J. Carter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALBIREO PHARMA, INC. Chief Regulatory Officer Common Stock 3.65K $160K $43.80 Mar 2, 2023 Direct
ALBIREO PHARMA, INC. Chief Regulatory Officer Restricted Stock Units 0 Mar 2, 2023 Direct
ALBIREO PHARMA, INC. Chief Regulatory Officer Stock Option (right to buy) 0 Mar 2, 2023 Direct

Insider Reports Filed by Martha J. Carter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALBO ALBIREO PHARMA, INC. Mar 2, 2023 10 $0 4 Mar 2, 2023 Chief Regulatory Officer
ALBO ALBIREO PHARMA, INC. Jan 23, 2023 1 -$5.26K 4 Jan 23, 2023 Chief Regulatory Officer
ALBO ALBIREO PHARMA, INC. Jan 19, 2023 1 $0 4/A Jan 27, 2023 Chief Regulatory Officer
ALBO ALBIREO PHARMA, INC. Jan 19, 2023 1 -$41.2K 4 Jan 20, 2023 Chief Regulatory Officer
ALBO ALBIREO PHARMA, INC. Oct 24, 2022 1 -$2.04K 4 Oct 25, 2022 Chief Regulatory Officer
ALBO ALBIREO PHARMA, INC. Jul 22, 2022 1 -$2.62K 4 Jul 25, 2022 Chief Regulatory Officer
ALBO ALBIREO PHARMA, INC. Apr 22, 2022 1 -$3.39K 4 Apr 25, 2022 Chief Regulatory Officer
ALBO ALBIREO PHARMA, INC. Jan 24, 2022 1 -$10.4K 4 Jan 25, 2022 Chief Regulatory Officer
ALBO ALBIREO PHARMA, INC. Jan 18, 2022 2 $0 4 Jan 20, 2022 Chief Regulatory Officer